Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
Lyft shares continue slide after Q4 earnings: here’s why the stock is down 14%
Stock Market

Lyft shares continue slide after Q4 earnings: here’s why the stock is down 14%

Lyft shares tumbled close to 14% in premarket trading on Wednesday after the company issued weaker-than-expected guidance for first-quarter gross bookings, raising concerns about its ability to compete with larger rival Uber Technologies. The sentiment is also hampered as several analysts have reduced their target price on the stock. The ride-hailing platform has been pursuing […]

  • February 12, 2025 04:56 AM PST
  • Invezz
Alkermes: Q4 Earnings Snapshot
Market Updates

Alkermes: Q4 Earnings Snapshot

DUBLIN (AP) — DUBLIN (AP) — Alkermes PLC (ALKS) on Wednesday reported fourth-quarter net income of $146.5 million. On a per-share basis, the Dublin-based company said it had net income of 88 cents. Ea...

  • February 12, 2025 04:54 AM PST
  • EODHD
Barrick Gold surpasses expectations with strong Q4 performance amid rising gold prices
Gold

Barrick Gold surpasses expectations with strong Q4 performance amid rising gold prices

Canada’s Barrick Gold Corporation exceeded analysts’ expectations for fourth-quarter profit, reporting higher earnings than anticipated.  The company attributed this positive performance to a combination of factors, including increased gold prices and a rise in gold production during the quarter.  This achievement highlights Barrick Gold’s ability to capitalise on favorable market conditions and operational efficiencies to […]

  • February 12, 2025 04:45 AM PST
  • Invezz
Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Market Updates

Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Completed Phase 2 enrollment with randomization of 51 subjects into treatment and control armsPhase 1/2 study (N=60) demonstrated favorable safety and tolerability profile with no serious adverse even...

  • February 12, 2025 04:42 AM PST
  • EODHD
Bitpanda gets green light from FCA, eyes UK expansion
Stock Market

Bitpanda gets green light from FCA, eyes UK expansion

Bitpanda, the European cryptocurrency investment platform, has secured approval from the UK’s Financial Conduct Authority (FCA), marking a strategic step in its push for regulated growth across Europe. The FCA’s authorisation allows Bitpanda to provide a full suite of crypto services to UK investors, including trading, staking, and savings plans. The approval comes at a […]

  • February 12, 2025 04:36 AM PST
  • Invezz
Camtek: Q4 Earnings Snapshot
Market Updates

Camtek: Q4 Earnings Snapshot

MIGDAL HAEMEK, Israel (AP) — MIGDAL HAEMEK, Israel (AP) — Camtek Ltd. (CAMT) on Wednesday reported fourth-quarter profit of $33 million. The Migdal Haemek, Israel-based company said it had net income...

  • February 12, 2025 04:36 AM PST
  • EODHD
Mr Cooper: Q4 Earnings Snapshot
Market Updates

Mr Cooper: Q4 Earnings Snapshot

COPPELL, Texas (AP) — COPPELL, Texas (AP) — Mr. Cooper Group Inc. (COOP) on Wednesday reported fourth-quarter profit of $204 million. The Coppell, Texas-based company said it had net income of $3.13 p...

  • February 12, 2025 04:18 AM PST
  • EODHD
Blackstone Mortgage: Q4 Earnings Snapshot
Market Updates

Blackstone Mortgage: Q4 Earnings Snapshot

NEW YORK (AP) — NEW YORK (AP) — Blackstone Mortgage Trust Inc. (BXMT) on Wednesday reported fourth-quarter net income of $37.2 million, after reporting a loss in the same period a year earlier. The Ne...

  • February 12, 2025 04:05 AM PST
  • EODHD